+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

CMO Market In Pharmaceutical Industry 2025-2029

  • PDF Icon

    Report

  • 208 Pages
  • June 2025
  • Region: Global
  • TechNavio
  • ID: 5514987
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cmo in pharmaceutical industry market is forecasted to grow by USD 42.7 million during 2024-2029, accelerating at a CAGR of 6.5% during the forecast period. The report on the cmo in pharmaceutical industry market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by availability of cost-efficient resources in emerging markets, growing need to focus on core competencies, and strong research funding.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

The cmo in pharmaceutical industry market is segmented as below:

By Service

  • API manufacturing
  • FDF manufacturing

By Drug Class

  • Small molecule
  • Drugs biologics
  • High potency drugs

By End-user

  • Big pharma
  • Small and medium enterprises (SMEs)
  • Generic drug manufacturers
  • Biotech companies

By Geographical Landscape

  • Europe
  • North America
  • APAC
  • Middle East and Africa
  • South America
This study identifies the us fda-approved manufacturing facilities as one of the prime reasons driving the cmo in pharmaceutical industry market growth during the next few years. Also, increasing number of contracts for manufacturing novel and advent of big data will lead to sizable demand in the market.

The report on the cmo in pharmaceutical industry market covers the following areas:

  • CMO In Pharmaceutical Industry Market sizing
  • CMO In Pharmaceutical Industry Market forecast
  • CMO In Pharmaceutical Industry Market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cmo in pharmaceutical industry market vendors that include Almac Group Ltd., Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Ltd., Cambrex Corp., Catalent Inc., Chongqing Huapont Pharmaceutical Co. Ltd., Cipla Inc., Cmic Holdings Co. Ltd, Curia Global Inc., Dr Reddys Laboratories Ltd., FAMAR Health Care Services, Jubilant Pharma Ltd., Lonza Group Ltd., Lupin Ltd., PCI Pharma Services, Pfizer Inc., Recipharm AB, Samsung Biologics Co. Ltd., Thermo Fisher Scientific Inc., and Vetter Pharma Fertigung GmbH and Co. KG. Also, the cmo in pharmaceutical industry market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Service
  • Executive Summary - Chart on Market Segmentation by Drug Class
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
  • Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
  • Overview on factors of disruption
2.4 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
3.2 Market characteristics
  • Market characteristics analysis
3.3 Value chain analysis
  • Value chain analysis
4 Market Sizing
4.1 Market definition
  • Offerings of companies included in the market definition
4.2 Market segment analysis
  • Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
  • Chart on Global - Market size and forecast 2024-2029 ($ million)
  • Data Table on Global - Market size and forecast 2024-2029 ($ million)
  • Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global CMO Market In Pharmaceutical Industry 2019 - 2023
  • Historic Market Size - Data Table on Global CMO Market In Pharmaceutical Industry 2019 - 2023 ($ million)
5.2 Service segment analysis 2019 - 2023
  • Historic Market Size - Service Segment 2019 - 2023 ($ million)
5.3 Drug Class segment analysis 2019 - 2023
  • Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
5.4 End-user segment analysis 2019 - 2023
  • Historic Market Size - End-user Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
  • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
  • Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 The AI impact on global CMO market in pharmaceutical industry
7 Five Forces Analysis
7.1 Five forces summary
  • Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
  • Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Service
8.1 Market segments
  • Chart on Service - Market share 2024-2029 (%)
  • Data Table on Service - Market share 2024-2029 (%)
8.2 Comparison by Service
  • Chart on Comparison by Service
  • Data Table on Comparison by Service
8.3 API manufacturing - Market size and forecast 2024-2029
  • Chart on API manufacturing - Market size and forecast 2024-2029 ($ million)
  • Data Table on API manufacturing - Market size and forecast 2024-2029 ($ million)
  • Chart on API manufacturing - Year-over-year growth 2024-2029 (%)
  • Data Table on API manufacturing - Year-over-year growth 2024-2029 (%)
8.4 FDF manufacturing - Market size and forecast 2024-2029
  • Chart on FDF manufacturing - Market size and forecast 2024-2029 ($ million)
  • Data Table on FDF manufacturing - Market size and forecast 2024-2029 ($ million)
  • Chart on FDF manufacturing - Year-over-year growth 2024-2029 (%)
  • Data Table on FDF manufacturing - Year-over-year growth 2024-2029 (%)
8.5 Market opportunity by Service
  • Market opportunity by Service ($ million)
  • Data Table on Market opportunity by Service ($ million)
9 Market Segmentation by Drug Class
9.1 Market segments
  • Chart on Drug Class - Market share 2024-2029 (%)
  • Data Table on Drug Class - Market share 2024-2029 (%)
9.2 Comparison by Drug Class
  • Chart on Comparison by Drug Class
  • Data Table on Comparison by Drug Class
9.3 Small molecule - Market size and forecast 2024-2029
  • Chart on Small molecule - Market size and forecast 2024-2029 ($ million)
  • Data Table on Small molecule - Market size and forecast 2024-2029 ($ million)
  • Chart on Small molecule - Year-over-year growth 2024-2029 (%)
  • Data Table on Small molecule - Year-over-year growth 2024-2029 (%)
9.4 Drugs biologics - Market size and forecast 2024-2029
  • Chart on Drugs biologics - Market size and forecast 2024-2029 ($ million)
  • Data Table on Drugs biologics - Market size and forecast 2024-2029 ($ million)
  • Chart on Drugs biologics - Year-over-year growth 2024-2029 (%)
  • Data Table on Drugs biologics - Year-over-year growth 2024-2029 (%)
9.5 High potency drugs - Market size and forecast 2024-2029
  • Chart on High potency drugs - Market size and forecast 2024-2029 ($ million)
  • Data Table on High potency drugs - Market size and forecast 2024-2029 ($ million)
  • Chart on High potency drugs - Year-over-year growth 2024-2029 (%)
  • Data Table on High potency drugs - Year-over-year growth 2024-2029 (%)
9.6 Market opportunity by Drug Class
  • Market opportunity by Drug Class ($ million)
  • Data Table on Market opportunity by Drug Class ($ million)
10 Market Segmentation by End-user
10.1 Market segments
  • Chart on End-user - Market share 2024-2029 (%)
  • Data Table on End-user - Market share 2024-2029 (%)
10.2 Comparison by End-user
  • Chart on Comparison by End-user
  • Data Table on Comparison by End-user
10.3 Big pharma - Market size and forecast 2024-2029
  • Chart on Big pharma - Market size and forecast 2024-2029 ($ million)
  • Data Table on Big pharma - Market size and forecast 2024-2029 ($ million)
  • Chart on Big pharma - Year-over-year growth 2024-2029 (%)
  • Data Table on Big pharma - Year-over-year growth 2024-2029 (%)
10.4 Small and medium enterprises (SMEs) - Market size and forecast 2024-2029
  • Chart on Small and medium enterprises (SMEs) - Market size and forecast 2024-2029 ($ million)
  • Data Table on Small and medium enterprises (SMEs) - Market size and forecast 2024-2029 ($ million)
  • Chart on Small and medium enterprises (SMEs) - Year-over-year growth 2024-2029 (%)
  • Data Table on Small and medium enterprises (SMEs) - Year-over-year growth 2024-2029 (%)
10.5 Generic drug manufacturers - Market size and forecast 2024-2029
  • Chart on Generic drug manufacturers - Market size and forecast 2024-2029 ($ million)
  • Data Table on Generic drug manufacturers - Market size and forecast 2024-2029 ($ million)
  • Chart on Generic drug manufacturers - Year-over-year growth 2024-2029 (%)
  • Data Table on Generic drug manufacturers - Year-over-year growth 2024-2029 (%)
10.6 Biotech companies - Market size and forecast 2024-2029
  • Chart on Biotech companies - Market size and forecast 2024-2029 ($ million)
  • Data Table on Biotech companies - Market size and forecast 2024-2029 ($ million)
  • Chart on Biotech companies - Year-over-year growth 2024-2029 (%)
  • Data Table on Biotech companies - Year-over-year growth 2024-2029 (%)
10.7 Market opportunity by End-user
  • Market opportunity by End-user ($ million)
  • Data Table on Market opportunity by End-user ($ million)
11 Customer Landscape
11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2024-2029 (%)
  • Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
12.3 Europe - Market size and forecast 2024-2029
  • Chart on Europe - Market size and forecast 2024-2029 ($ million)
  • Data Table on Europe - Market size and forecast 2024-2029 ($ million)
  • Chart on Europe - Year-over-year growth 2024-2029 (%)
  • Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.4 North America - Market size and forecast 2024-2029
  • Chart on North America - Market size and forecast 2024-2029 ($ million)
  • Data Table on North America - Market size and forecast 2024-2029 ($ million)
  • Chart on North America - Year-over-year growth 2024-2029 (%)
  • Data Table on North America - Year-over-year growth 2024-2029 (%)
12.5 APAC - Market size and forecast 2024-2029
  • Chart on APAC - Market size and forecast 2024-2029 ($ million)
  • Data Table on APAC - Market size and forecast 2024-2029 ($ million)
  • Chart on APAC - Year-over-year growth 2024-2029 (%)
  • Data Table on APAC - Year-over-year growth 2024-2029 (%)
12.6 Middle East and Africa - Market size and forecast 2024-2029
  • Chart on Middle East and Africa - Market size and forecast 2024-2029 ($ million)
  • Data Table on Middle East and Africa - Market size and forecast 2024-2029 ($ million)
  • Chart on Middle East and Africa - Year-over-year growth 2024-2029 (%)
  • Data Table on Middle East and Africa - Year-over-year growth 2024-2029 (%)
12.7 South America - Market size and forecast 2024-2029
  • Chart on South America - Market size and forecast 2024-2029 ($ million)
  • Data Table on South America - Market size and forecast 2024-2029 ($ million)
  • Chart on South America - Year-over-year growth 2024-2029 (%)
  • Data Table on South America - Year-over-year growth 2024-2029 (%)
12.8 US - Market size and forecast 2024-2029
  • Chart on US - Market size and forecast 2024-2029 ($ million)
  • Data Table on US - Market size and forecast 2024-2029 ($ million)
  • Chart on US - Year-over-year growth 2024-2029 (%)
  • Data Table on US - Year-over-year growth 2024-2029 (%)
12.9 Germany - Market size and forecast 2024-2029
  • Chart on Germany - Market size and forecast 2024-2029 ($ million)
  • Data Table on Germany - Market size and forecast 2024-2029 ($ million)
  • Chart on Germany - Year-over-year growth 2024-2029 (%)
  • Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.10 China - Market size and forecast 2024-2029
  • Chart on China - Market size and forecast 2024-2029 ($ million)
  • Data Table on China - Market size and forecast 2024-2029 ($ million)
  • Chart on China - Year-over-year growth 2024-2029 (%)
  • Data Table on China - Year-over-year growth 2024-2029 (%)
12.11 France - Market size and forecast 2024-2029
  • Chart on France - Market size and forecast 2024-2029 ($ million)
  • Data Table on France - Market size and forecast 2024-2029 ($ million)
  • Chart on France - Year-over-year growth 2024-2029 (%)
  • Data Table on France - Year-over-year growth 2024-2029 (%)
12.12 Canada - Market size and forecast 2024-2029
  • Chart on Canada - Market size and forecast 2024-2029 ($ million)
  • Data Table on Canada - Market size and forecast 2024-2029 ($ million)
  • Chart on Canada - Year-over-year growth 2024-2029 (%)
  • Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.13 UK - Market size and forecast 2024-2029
  • Chart on UK - Market size and forecast 2024-2029 ($ million)
  • Data Table on UK - Market size and forecast 2024-2029 ($ million)
  • Chart on UK - Year-over-year growth 2024-2029 (%)
  • Data Table on UK - Year-over-year growth 2024-2029 (%)
12.14 Italy - Market size and forecast 2024-2029
  • Chart on Italy - Market size and forecast 2024-2029 ($ million)
  • Data Table on Italy - Market size and forecast 2024-2029 ($ million)
  • Chart on Italy - Year-over-year growth 2024-2029 (%)
  • Data Table on Italy - Year-over-year growth 2024-2029 (%)
12.15 Spain - Market size and forecast 2024-2029
  • Chart on Spain - Market size and forecast 2024-2029 ($ million)
  • Data Table on Spain - Market size and forecast 2024-2029 ($ million)
  • Chart on Spain - Year-over-year growth 2024-2029 (%)
  • Data Table on Spain - Year-over-year growth 2024-2029 (%)
12.16 Japan - Market size and forecast 2024-2029
  • Chart on Japan - Market size and forecast 2024-2029 ($ million)
  • Data Table on Japan - Market size and forecast 2024-2029 ($ million)
  • Chart on Japan - Year-over-year growth 2024-2029 (%)
  • Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.17 India - Market size and forecast 2024-2029
  • Chart on India - Market size and forecast 2024-2029 ($ million)
  • Data Table on India - Market size and forecast 2024-2029 ($ million)
  • Chart on India - Year-over-year growth 2024-2029 (%)
  • Data Table on India - Year-over-year growth 2024-2029 (%)
12.18 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)
13 Drivers, Challenges, and Opportunity/Restraints
13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
  • Overview on factors of disruption
14.4 Industry risks
  • Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
  • Companies covered
15.2 Company ranking index
  • Company ranking index
15.3 Market positioning of companies
  • Matrix on companies position and classification
15.4 Almac Group Ltd.
  • Almac Group Ltd. - Overview
  • Almac Group Ltd. - Product / Service
  • Almac Group Ltd. - Key offerings
  • SWOT
15.5 Boehringer Ingelheim International GmbH
  • Boehringer Ingelheim International GmbH - Overview
  • Boehringer Ingelheim International GmbH - Product / Service
  • Boehringer Ingelheim International GmbH - Key news
  • Boehringer Ingelheim International GmbH - Key offerings
  • SWOT
15.6 Cadila Pharmaceuticals Ltd.
  • Cadila Pharmaceuticals Ltd. - Overview
  • Cadila Pharmaceuticals Ltd. - Product / Service
  • Cadila Pharmaceuticals Ltd. - Key offerings
  • SWOT
15.7 Cambrex Corp.
  • Cambrex Corp. - Overview
  • Cambrex Corp. - Product / Service
  • Cambrex Corp. - Key news
  • Cambrex Corp. - Key offerings
  • SWOT
15.8 Catalent Inc.
  • Catalent Inc. - Overview
  • Catalent Inc. - Business segments
  • Catalent Inc. - Key offerings
  • Catalent Inc. - Segment focus
  • SWOT
15.9 Cipla Inc.
  • Cipla Inc. - Overview
  • Cipla Inc. - Business segments
  • Cipla Inc. - Key news
  • Cipla Inc. - Key offerings
  • Cipla Inc. - Segment focus
  • SWOT
15.10 Cmic Holdings Co. Ltd
  • Cmic Holdings Co. Ltd - Overview
  • Cmic Holdings Co. Ltd - Business segments
  • Cmic Holdings Co. Ltd - Key offerings
  • Cmic Holdings Co. Ltd - Segment focus
  • SWOT
15.11 Curia Global Inc.
  • Curia Global Inc. - Overview
  • Curia Global Inc. - Product / Service
  • Curia Global Inc. - Key offerings
  • SWOT
15.12 Dr Reddys Laboratories Ltd.
  • Dr Reddys Laboratories Ltd. - Overview
  • Dr Reddys Laboratories Ltd. - Business segments
  • Dr Reddys Laboratories Ltd. - Key news
  • Dr Reddys Laboratories Ltd. - Key offerings
  • Dr Reddys Laboratories Ltd. - Segment focus
  • SWOT
15.13 FAMAR Health Care Services
  • FAMAR Health Care Services - Overview
  • FAMAR Health Care Services - Product / Service
  • FAMAR Health Care Services - Key offerings
  • SWOT
15.14 Jubilant Pharma Ltd.
  • Jubilant Pharma Ltd. - Overview
  • Jubilant Pharma Ltd. - Product / Service
  • Jubilant Pharma Ltd. - Key offerings
  • SWOT
15.15 Lonza Group Ltd.
  • Lonza Group Ltd. - Overview
  • Lonza Group Ltd. - Business segments
  • Lonza Group Ltd. - Key news
  • Lonza Group Ltd. - Key offerings
  • Lonza Group Ltd. - Segment focus
  • SWOT
15.16 Lupin Ltd.
  • Lupin Ltd. - Overview
  • Lupin Ltd. - Business segments
  • Lupin Ltd. - Key news
  • Lupin Ltd. - Key offerings
  • Lupin Ltd. - Segment focus
  • SWOT
15.17 Pfizer Inc.
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Product / Service
  • Pfizer Inc. - Key news
  • Pfizer Inc. - Key offerings
  • SWOT
15.18 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
  • SWOT
16 Appendix
16.1 Scope of the report
16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
16.4 Research methodology
  • Research methodology
16.5 Data procurement
  • Information sources
16.6 Data validation
  • Data validation
16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
16.8 Data synthesis
  • Data synthesis
16.9 360 degree market analysis
  • 360 degree market analysis
16.10 List of abbreviations
  • List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Service
Exhibits 6: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibits 7: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 8: Executive Summary - Chart on Incremental Growth
Exhibits 9: Executive Summary - Data Table on Incremental Growth
Exhibits 10: Executive Summary - Chart on Company Market Positioning
Exhibits 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 12: Overview on criticality of inputs and factors of differentiation
Exhibits 13: Overview on factors of disruption
Exhibits 14: Impact of drivers and challenges in 2024 and 2029
Exhibits 15: Parent Market
Exhibits 16: Data Table on - Parent Market
Exhibits 17: Market characteristics analysis
Exhibits 18: Value chain analysis
Exhibits 19: Offerings of companies included in the market definition
Exhibits 20: Market segments
Exhibits 21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 25: Historic Market Size - Data Table on Global CMO Market In Pharmaceutical Industry 2019 - 2023 ($ million)
Exhibits 26: Historic Market Size - Service Segment 2019 - 2023 ($ million)
Exhibits 27: Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
Exhibits 28: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
Exhibits 29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits 30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits 31: Five forces analysis - Comparison between 2024 and 2029
Exhibits 32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits 33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits 34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits 35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits 36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits 37: Chart on Market condition - Five forces 2024 and 2029
Exhibits 38: Chart on Service - Market share 2024-2029 (%)
Exhibits 39: Data Table on Service - Market share 2024-2029 (%)
Exhibits 40: Chart on Comparison by Service
Exhibits 41: Data Table on Comparison by Service
Exhibits 42: Chart on API manufacturing - Market size and forecast 2024-2029 ($ million)
Exhibits 43: Data Table on API manufacturing - Market size and forecast 2024-2029 ($ million)
Exhibits 44: Chart on API manufacturing - Year-over-year growth 2024-2029 (%)
Exhibits 45: Data Table on API manufacturing - Year-over-year growth 2024-2029 (%)
Exhibits 46: Chart on FDF manufacturing - Market size and forecast 2024-2029 ($ million)
Exhibits 47: Data Table on FDF manufacturing - Market size and forecast 2024-2029 ($ million)
Exhibits 48: Chart on FDF manufacturing - Year-over-year growth 2024-2029 (%)
Exhibits 49: Data Table on FDF manufacturing - Year-over-year growth 2024-2029 (%)
Exhibits 50: Market opportunity by Service ($ million)
Exhibits 51: Data Table on Market opportunity by Service ($ million)
Exhibits 52: Chart on Drug Class - Market share 2024-2029 (%)
Exhibits 53: Data Table on Drug Class - Market share 2024-2029 (%)
Exhibits 54: Chart on Comparison by Drug Class
Exhibits 55: Data Table on Comparison by Drug Class
Exhibits 56: Chart on Small molecule - Market size and forecast 2024-2029 ($ million)
Exhibits 57: Data Table on Small molecule - Market size and forecast 2024-2029 ($ million)
Exhibits 58: Chart on Small molecule - Year-over-year growth 2024-2029 (%)
Exhibits 59: Data Table on Small molecule - Year-over-year growth 2024-2029 (%)
Exhibits 60: Chart on Drugs biologics - Market size and forecast 2024-2029 ($ million)
Exhibits 61: Data Table on Drugs biologics - Market size and forecast 2024-2029 ($ million)
Exhibits 62: Chart on Drugs biologics - Year-over-year growth 2024-2029 (%)
Exhibits 63: Data Table on Drugs biologics - Year-over-year growth 2024-2029 (%)
Exhibits 64: Chart on High potency drugs - Market size and forecast 2024-2029 ($ million)
Exhibits 65: Data Table on High potency drugs - Market size and forecast 2024-2029 ($ million)
Exhibits 66: Chart on High potency drugs - Year-over-year growth 2024-2029 (%)
Exhibits 67: Data Table on High potency drugs - Year-over-year growth 2024-2029 (%)
Exhibits 68: Market opportunity by Drug Class ($ million)
Exhibits 69: Data Table on Market opportunity by Drug Class ($ million)
Exhibits 70: Chart on End-user - Market share 2024-2029 (%)
Exhibits 71: Data Table on End-user - Market share 2024-2029 (%)
Exhibits 72: Chart on Comparison by End-user
Exhibits 73: Data Table on Comparison by End-user
Exhibits 74: Chart on Big pharma - Market size and forecast 2024-2029 ($ million)
Exhibits 75: Data Table on Big pharma - Market size and forecast 2024-2029 ($ million)
Exhibits 76: Chart on Big pharma - Year-over-year growth 2024-2029 (%)
Exhibits 77: Data Table on Big pharma - Year-over-year growth 2024-2029 (%)
Exhibits 78: Chart on Small and medium enterprises (SMEs) - Market size and forecast 2024-2029 ($ million)
Exhibits 79: Data Table on Small and medium enterprises (SMEs) - Market size and forecast 2024-2029 ($ million)
Exhibits 80: Chart on Small and medium enterprises (SMEs) - Year-over-year growth 2024-2029 (%)
Exhibits 81: Data Table on Small and medium enterprises (SMEs) - Year-over-year growth 2024-2029 (%)
Exhibits 82: Chart on Generic drug manufacturers - Market size and forecast 2024-2029 ($ million)
Exhibits 83: Data Table on Generic drug manufacturers - Market size and forecast 2024-2029 ($ million)
Exhibits 84: Chart on Generic drug manufacturers - Year-over-year growth 2024-2029 (%)
Exhibits 85: Data Table on Generic drug manufacturers - Year-over-year growth 2024-2029 (%)
Exhibits 86: Chart on Biotech companies - Market size and forecast 2024-2029 ($ million)
Exhibits 87: Data Table on Biotech companies - Market size and forecast 2024-2029 ($ million)
Exhibits 88: Chart on Biotech companies - Year-over-year growth 2024-2029 (%)
Exhibits 89: Data Table on Biotech companies - Year-over-year growth 2024-2029 (%)
Exhibits 90: Market opportunity by End-user ($ million)
Exhibits 91: Data Table on Market opportunity by End-user ($ million)
Exhibits 92: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 93: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 94: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 95: Chart on Geographic comparison
Exhibits 96: Data Table on Geographic comparison
Exhibits 97: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 98: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 99: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 100: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 101: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 102: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 103: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits 104: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits 105: Chart on APAC - Market size and forecast 2024-2029 ($ million)
Exhibits 106: Data Table on APAC - Market size and forecast 2024-2029 ($ million)
Exhibits 107: Chart on APAC - Year-over-year growth 2024-2029 (%)
Exhibits 108: Data Table on APAC - Year-over-year growth 2024-2029 (%)
Exhibits 109: Chart on Middle East and Africa - Market size and forecast 2024-2029 ($ million)
Exhibits 110: Data Table on Middle East and Africa - Market size and forecast 2024-2029 ($ million)
Exhibits 111: Chart on Middle East and Africa - Year-over-year growth 2024-2029 (%)
Exhibits 112: Data Table on Middle East and Africa - Year-over-year growth 2024-2029 (%)
Exhibits 113: Chart on South America - Market size and forecast 2024-2029 ($ million)
Exhibits 114: Data Table on South America - Market size and forecast 2024-2029 ($ million)
Exhibits 115: Chart on South America - Year-over-year growth 2024-2029 (%)
Exhibits 116: Data Table on South America - Year-over-year growth 2024-2029 (%)
Exhibits 117: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits 118: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits 119: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits 120: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits 121: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 122: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 123: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 124: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 125: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits 126: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits 127: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits 128: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits 129: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits 130: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits 131: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits 132: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits 133: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 134: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 135: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 136: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 137: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 138: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 139: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits 140: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits 141: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits 142: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits 143: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits 144: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits 145: Chart on Spain - Market size and forecast 2024-2029 ($ million)
Exhibits 146: Data Table on Spain - Market size and forecast 2024-2029 ($ million)
Exhibits 147: Chart on Spain - Year-over-year growth 2024-2029 (%)
Exhibits 148: Data Table on Spain - Year-over-year growth 2024-2029 (%)
Exhibits 149: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 150: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 151: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 152: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 153: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits 154: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits 155: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits 156: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits 157: Market opportunity By Geographical Landscape ($ million)
Exhibits 158: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 159: Impact of drivers and challenges in 2024 and 2029
Exhibits 160: Overview on criticality of inputs and factors of differentiation
Exhibits 161: Overview on factors of disruption
Exhibits 162: Impact of key risks on business
Exhibits 163: Companies covered
Exhibits 164: Company ranking index
Exhibits 165: Matrix on companies position and classification
Exhibits 166: Almac Group Ltd. - Overview
Exhibits 167: Almac Group Ltd. - Product / Service
Exhibits 168: Almac Group Ltd. - Key offerings
Exhibits 169: SWOT
Exhibits 170: Boehringer Ingelheim International GmbH - Overview
Exhibits 171: Boehringer Ingelheim International GmbH - Product / Service
Exhibits 172: Boehringer Ingelheim International GmbH - Key news
Exhibits 173: Boehringer Ingelheim International GmbH - Key offerings
Exhibits 174: SWOT
Exhibits 175: Cadila Pharmaceuticals Ltd. - Overview
Exhibits 176: Cadila Pharmaceuticals Ltd. - Product / Service
Exhibits 177: Cadila Pharmaceuticals Ltd. - Key offerings
Exhibits 178: SWOT
Exhibits 179: Cambrex Corp. - Overview
Exhibits 180: Cambrex Corp. - Product / Service
Exhibits 181: Cambrex Corp. - Key news
Exhibits 182: Cambrex Corp. - Key offerings
Exhibits 183: SWOT
Exhibits 184: Catalent Inc. - Overview
Exhibits 185: Catalent Inc. - Business segments
Exhibits 186: Catalent Inc. - Key offerings
Exhibits 187: Catalent Inc. - Segment focus
Exhibits 188: SWOT
Exhibits 189: Cipla Inc. - Overview
Exhibits 190: Cipla Inc. - Business segments
Exhibits 191: Cipla Inc. - Key news
Exhibits 192: Cipla Inc. - Key offerings
Exhibits 193: Cipla Inc. - Segment focus
Exhibits 194: SWOT
Exhibits 195: Cmic Holdings Co. Ltd - Overview
Exhibits 196: Cmic Holdings Co. Ltd - Business segments
Exhibits 197: Cmic Holdings Co. Ltd - Key offerings
Exhibits 198: Cmic Holdings Co. Ltd - Segment focus
Exhibits 199: SWOT
Exhibits 200: Curia Global Inc. - Overview
Exhibits 201: Curia Global Inc. - Product / Service
Exhibits 202: Curia Global Inc. - Key offerings
Exhibits 203: SWOT
Exhibits 204: Dr Reddys Laboratories Ltd. - Overview
Exhibits 205: Dr Reddys Laboratories Ltd. - Business segments
Exhibits 206: Dr Reddys Laboratories Ltd. - Key news
Exhibits 207: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits 208: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits 209: SWOT
Exhibits 210: FAMAR Health Care Services - Overview
Exhibits 211: FAMAR Health Care Services - Product / Service
Exhibits 212: FAMAR Health Care Services - Key offerings
Exhibits 213: SWOT
Exhibits 214: Jubilant Pharma Ltd. - Overview
Exhibits 215: Jubilant Pharma Ltd. - Product / Service
Exhibits 216: Jubilant Pharma Ltd. - Key offerings
Exhibits 217: SWOT
Exhibits 218: Lonza Group Ltd. - Overview
Exhibits 219: Lonza Group Ltd. - Business segments
Exhibits 220: Lonza Group Ltd. - Key news
Exhibits 221: Lonza Group Ltd. - Key offerings
Exhibits 222: Lonza Group Ltd. - Segment focus
Exhibits 223: SWOT
Exhibits 224: Lupin Ltd. - Overview
Exhibits 225: Lupin Ltd. - Business segments
Exhibits 226: Lupin Ltd. - Key news
Exhibits 227: Lupin Ltd. - Key offerings
Exhibits 228: Lupin Ltd. - Segment focus
Exhibits 229: SWOT
Exhibits 230: Pfizer Inc. - Overview
Exhibits 231: Pfizer Inc. - Product / Service
Exhibits 232: Pfizer Inc. - Key news
Exhibits 233: Pfizer Inc. - Key offerings
Exhibits 234: SWOT
Exhibits 235: Thermo Fisher Scientific Inc. - Overview
Exhibits 236: Thermo Fisher Scientific Inc. - Business segments
Exhibits 237: Thermo Fisher Scientific Inc. - Key news
Exhibits 238: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 239: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 240: SWOT
Exhibits 241: Inclusions checklist
Exhibits 242: Exclusions checklist
Exhibits 243: Currency conversion rates for US$
Exhibits 244: Research methodology
Exhibits 245: Information sources
Exhibits 246: Data validation
Exhibits 247: Validation techniques employed for market sizing
Exhibits 248: Data synthesis
Exhibits 249: 360 degree market analysis
Exhibits 250: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global CMO in pharmaceutical industry market: Almac Group Ltd., Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Ltd., Cambrex Corp., Catalent Inc., Chongqing Huapont Pharmaceutical Co. Ltd., Cipla Inc., Cmic Holdings Co. Ltd, Curia Global Inc., DR Reddys Laboratories Ltd., FAMAR Health Care Services, Jubilant Pharma Ltd., Lonza Group Ltd., Lupin Ltd., PCI Pharma Services, Pfizer Inc., Recipharm AB, Samsung Biologics Co. Ltd., Thermo Fisher Scientific Inc., and Vetter Pharma Fertigung GmbH and Co. KG.

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is US FDA-approved manufacturing facilities."

According to the report, one of the major drivers for this market is the availability of cost-efficient resources in emerging markets.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Almac Group Ltd.
  • Boehringer Ingelheim International GmbH
  • Cadila Pharmaceuticals Ltd.
  • Cambrex Corp.
  • Catalent Inc.
  • Chongqing Huapont Pharmaceutical Co. Ltd.
  • Cipla Inc.
  • Cmic Holdings Co. Ltd
  • Curia Global Inc.
  • Dr Reddys Laboratories Ltd.
  • FAMAR Health Care Services
  • Jubilant Pharma Ltd.
  • Lonza Group Ltd.
  • Lupin Ltd.
  • PCI Pharma Services
  • Pfizer Inc.
  • Recipharm AB
  • Samsung Biologics Co. Ltd.
  • Thermo Fisher Scientific Inc.
  • Vetter Pharma Fertigung GmbH and Co. KG